Research team unveils new potential for drugs

After screening some 3,700 compounds, a research team at the Center for Human Genetic Research found several drugs that influence the cells' conversion of nutrients into energy. And those drugs have newfound potential for treating heart attacks, stroke and other ailments. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.